Soleus Capital Management’s Enliven Therapeutics ELVN Stock Holding History

Soleus Capital Management’s Portfolio ELVN Stock Details ELVN Fund Activity

Upgrade to unlock

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q4	$15.8M	Buy
2025 Q1	–	Sell
2024 Q4	$1.7M	Sell
2024 Q3	$6.12M	Sell
2024 Q2	$18M	Buy